Skip to main content
Top
Published in: Clinical Rheumatology 6/2007

01-06-2007 | Brief Report

Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis

Authors: Pilar Peris, Ana Monegal, M. Angeles Martínez, Concepción Moll, Françesca Pons, Nuria Guañabens

Published in: Clinical Rheumatology | Issue 6/2007

Login to get access

Abstract

Idiopathic osteoporosis is a frequent cause of osteoporosis in young premenopausal women. However, there are no data about the treatment of these patients. The aim of this study was to analyse the evolution of bone mineral density (BMD) in premenopausal women with idiopathic osteoporosis treated with a conservative approach. Retrospective study of 16 premenopausal women with idiopathic osteoporosis (aged 35.7±7 years) with a mean follow-up period of 3 years (1–6 years). BMD measurements at the lumbar spine and femoral neck were obtained in all patients at baseline and yearly (patients had one or more fragility fractures and/or a Z score <−2 in the lumbar spine or femur). Secondary causes of osteoporosis were excluded in all patients. Patients were treated with calcium and vitamin D to achieve a calcium intake of up to 1,500 mg/day and were advised to increase physical activity. A significant increase in lumbar and femoral BMD was observed after 2 and 3 years of follow-up, respectively (1.9±1.9% mean increase in lumbar spine, p= 0.021, at 2 years) (5.6±4.5% mean increase in femur, p=0.04, at 3 years). The serum total alkaline phosphatase (TAP) values increased at 2 years (122±46 vs 140±36 U/l, p=0.054). In addition, a negative correlation between baseline TAP serum values and lumbar BMD evolution at 2 years was observed (r=−0.748, p=0.013). No patient developed new skeletal fractures during the follow-up period. In young premenopausal women with idiopathic osteoporosis the conservative treatment with supplements of calcium and vitamin D associated with an increase of physical activity is associated with an increase in BMD without evidence of further skeletal fractures after more than 3 years of follow-up.
Literature
1.
go back to reference Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406PubMedCrossRef Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406PubMedCrossRef
2.
go back to reference Díaz Curiel M, García JJ, Carrasco JL, Honorato J, Pérez Cano R, Rapado A et al (2001) Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc) 116:86–88 Díaz Curiel M, García JJ, Carrasco JL, Honorato J, Pérez Cano R, Rapado A et al (2001) Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc) 116:86–88
3.
go back to reference Peris P, Guañabens N, Martínez de Osaba MJ, Monegal A, Alvarez L, Pons F et al (2002) Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 32:64–70PubMedCrossRef Peris P, Guañabens N, Martínez de Osaba MJ, Monegal A, Alvarez L, Pons F et al (2002) Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 32:64–70PubMedCrossRef
4.
go back to reference Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7:1–5PubMedCrossRef Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7:1–5PubMedCrossRef
6.
go back to reference Rubin MR, Schussheim DH, Kulak CAM, Kurland ES, Rosen CJ, Bilezikian JP et al (2005) Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526–533PubMedCrossRef Rubin MR, Schussheim DH, Kulak CAM, Kurland ES, Rosen CJ, Bilezikian JP et al (2005) Idiopathic osteoporosis in premenopausal women. Osteoporos Int 16:526–533PubMedCrossRef
7.
go back to reference Leib ES (2005) Treatment of low bone mass in premenopausal women: when may it be appropriate? Current Osteoporosis Reports 3:13–18PubMed Leib ES (2005) Treatment of low bone mass in premenopausal women: when may it be appropriate? Current Osteoporosis Reports 3:13–18PubMed
8.
go back to reference Wolff I, Van Croonenberg JJ, Kemper HC, Kostense PJ, Twisk JW (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9:1–12PubMedCrossRef Wolff I, Van Croonenberg JJ, Kemper HC, Kostense PJ, Twisk JW (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9:1–12PubMedCrossRef
9.
go back to reference Welten DC, Kemper HCG, Post GB, Mechelen WV, Twisk J, Lips P et al (1994) Weight bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res 9:1089–1095PubMed Welten DC, Kemper HCG, Post GB, Mechelen WV, Twisk J, Lips P et al (1994) Weight bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res 9:1089–1095PubMed
10.
go back to reference Feskanich D, Willett W, Colditz G (2002) Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 288:2300–2306PubMedCrossRef Feskanich D, Willett W, Colditz G (2002) Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 288:2300–2306PubMedCrossRef
11.
go back to reference Mein AL, Briffa NK, Dhaliwal SS, Prince R (2004) Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 19:1092–1098PubMedCrossRef Mein AL, Briffa NK, Dhaliwal SS, Prince R (2004) Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 19:1092–1098PubMedCrossRef
12.
go back to reference Vainionpää A, Korpelainen R, Leppäluoto J, Jämsä T (2005) Effects of high-impact exercise on bone mineral density: a randomised controlled trial in premenopausal women. Osteoporos Int 16:191–197PubMedCrossRef Vainionpää A, Korpelainen R, Leppäluoto J, Jämsä T (2005) Effects of high-impact exercise on bone mineral density: a randomised controlled trial in premenopausal women. Osteoporos Int 16:191–197PubMedCrossRef
13.
go back to reference Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al (1992) Vitamin D3 and calcium prevent hip fractures in elderly women. N Engl J Med 327:1637–1642PubMedCrossRef Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al (1992) Vitamin D3 and calcium prevent hip fractures in elderly women. N Engl J Med 327:1637–1642PubMedCrossRef
14.
go back to reference Reid IA, Ames RW, Evans MC, Gamble GD, Sharpe SJ (1995) Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomised controlled trial. Am J Med 98:331–335PubMedCrossRef Reid IA, Ames RW, Evans MC, Gamble GD, Sharpe SJ (1995) Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomised controlled trial. Am J Med 98:331–335PubMedCrossRef
15.
go back to reference Lloyd T, Andon M, Rollings N, Martel JR, Landis JR, Demers LM et al (1993) Calcium supplementation and bone mineral density in adolescent girls. JAMA 270:841–844PubMedCrossRef Lloyd T, Andon M, Rollings N, Martel JR, Landis JR, Demers LM et al (1993) Calcium supplementation and bone mineral density in adolescent girls. JAMA 270:841–844PubMedCrossRef
16.
go back to reference Baran D, Sorensen A, Grimes J, Lew R, Karellas A, Johnson B et al (1990) Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab 70:264–270PubMedCrossRef Baran D, Sorensen A, Grimes J, Lew R, Karellas A, Johnson B et al (1990) Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab 70:264–270PubMedCrossRef
17.
go back to reference Elders PJM, Lips P, Netelenbos JC, Van Ginkel FC, Khoe E, Van Der Vijgh WJF et al (1994) Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9:963–970PubMedCrossRef Elders PJM, Lips P, Netelenbos JC, Van Ginkel FC, Khoe E, Van Der Vijgh WJF et al (1994) Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9:963–970PubMedCrossRef
Metadata
Title
Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis
Authors
Pilar Peris
Ana Monegal
M. Angeles Martínez
Concepción Moll
Françesca Pons
Nuria Guañabens
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0405-0

Other articles of this Issue 6/2007

Clinical Rheumatology 6/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine